Abstract
Objective
To identify in appendicular Ewing sarcoma (ES), if skip metastases (SM) are associated with distant metastases at presentation, response to neoadjuvant chemotherapy and overall outcome.
Materials and method
Patients with appendicular ES from 2007 to 2021 who had whole-bone MRI to identify SM were included in the study. Patient demographics included age/gender, bone involved, the presence of SM, longitudinal tumour length, presence of extra-osseous disease and its axial depth if present from whole-bone MRI and lung metastases and distant bone metastases from staging studies. Response to neoadjuvant chemotherapy from resection specimens and overall survival were noted. Comparison of these factors between patients with and without SM was undertaken.
Results
Ninety-five patients (66 males; 29 females: mean age 15.8 years; range 5–48 years) were included. On whole-bone MRI, 80 (84.2%) patients had no SM and 15 (15.8%) patients had one or more SM. Of patients without a SM, lung metastases were present in 16 (21%), distant bone metastases in 7 (11%), while 51 (75%) had a good response to chemotherapy compared with 7 (50%), 3 (27%), and 10 (77%), respectively, in patients with a SM. SM were significantly associated with lung metastases (p = 0.02), but not with distant skeletal metastases (p = 0.13), chemotherapy response (p = 0.88), tumour length (p = 0.47), presence of (p = 0.15) or axial depth of extra-osseous disease (p = 0.4). SM were associated with a significantly poorer survival (p = 0.007) and three times greater risk of death during follow-up.
Conclusions
In appendicular ES, the identification of a SM is associated with the presence of lung metastases at presentation and poorer survival.
Similar content being viewed by others
References
WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours. Lyon (France). International Agency for Research on Cancer; 2020. (WHO Classification of Tumours Series. 5th Ed.; Volume 3). https://publications.iarc.fr/588
Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, Peake D, Seddon B, Whelan J. British Sarcoma Group. UK guidelines for the management of bone sarcomas. Clin Sarcoma Res. 2016;4(6):7.
Saifuddin A, Sharif B, Oliveira I, Kalus S, Barnett J, Pressney I. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas. Skeletal Radiol. 2020;49(6):945–54.
Barnett JR, Gikas P, Gerrand C, Briggs TW, Saifuddin A. The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma. Skeletal Radiol. 2020;49(6):913–9.
Jiya TU, Wuisman PI. Long-term follow-up of 15 patients with non-metastatic Ewing’s sarcoma and a skip lesion. Acta Orthop. 2005;76(6):899–903.
Yang P, Gilg M, Evans S, Totti F, Stevenson J, Jeys L, Parry M. Survival of osteosarcoma patients following diagnosis of synchronous skip metastases. J Orthop. 2019;24(18):121–5.
Saifuddin A, Michelagnoli M, Pressney I. Skip metastases in high-grade intramedullary appendicular osteosarcoma: an indicator of more aggressive disease? Skeletal Radiol. 2021;50(12):2415–22.
Saifuddin A, Shafiq H, Rajakulasingam R, Tan A, O’Donnell P, Khoo M. A review of staging chest CT in trunk and extremity soft tissue sarcoma. Br J Radiol. 2021;94(1118):20201109.
Kalus S, Saifuddin A. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review. Eur Radiol. 2019;29(10):5700–8.
Bosma SE, Lancia C, Rueten-Budde AJ, Ranft A, et al. Easy to use scientific tool for survival estimation in Ewing sarcoma at diagnosis and after surgery. Sci Rep. 2019;9:11000.
Tanaka K, Ozaki T. New TNM classification AJCC eighth edition of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group. Jpn J Clin Oncol. 2019;49(2):103–7.
Acknowledgements
The authors thank Mr Paul Bassett for statistical input.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saifuddin, A., Michelagnoli, M. & Pressney, I. Skip metastases in appendicular Ewing sarcoma: relationship to distant metastases at diagnosis, chemotherapy response and overall survival. Skeletal Radiol 52, 585–591 (2023). https://doi.org/10.1007/s00256-022-04180-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-022-04180-9